Rayyan vs Iris.ai (2026)

Rayyan

by Rayyan

Iris.ai

by Iris.ai

Pros

• ✓Academic-friendly pricing with free tier and student tier is genuinely differentiated — Free for early-career researchers and $4.99/seat student tier make systematic review tools accessible to individual researchers and graduate students that find Covidence or DistillerSR enterprise pricing prohibitive
• ✓Industry-leading duplicate detection — Rayyan's duplicate detection is widely regarded as the best in the systematic review category, materially better than alternatives that produce more false negatives in deduplication
• ✓1M+ researcher installed base provides community resources and validation — extensive global adoption produces materially more learning materials, peer references, and methodology examples than smaller systematic review alternatives

Limitations

• ⚠Less depth than enterprise systematic review tools (Covidence, DistillerSR) — Rayyan is solid for academic and SMB systematic review but lacks the workflow customization, advanced reporting, and enterprise-specific features that dedicated commercial alternatives provide for high-stakes regulatory and clinical work
• ⚠Free tier limits create scaling friction — 3 active reviews and 2 reviewers per review on Free tier require upgrade for active research teams, meaningful for cost-conscious individual researchers but limiting for productive research operations
• ⚠Specialized for systematic reviews limits broader research use cases — Rayyan is purpose-built for evidence synthesis and lacks the broader literature search, citation analysis, and AI research capabilities that horizontal AI research tools (Elicit, Scite.ai, SciSpace) provide

Pros

• ✓Regulated enterprise focus is genuinely differentiated — Iris.ai's data foundation and knowledge graph approach addresses a category gap that general AI platforms cannot fill for regulated industries needing AI-ready data preparation before deployment
• ✓10+ year track record (since 2015) provides operational maturity — sustained platform development longer than most enterprise AI challengers means better feature depth, integration breadth, and enterprise customer learnings
• ✓Three-product architecture (Axion + Neuralith + RSpace) covers full data-to-AI lifecycle — from data preparation through knowledge engine to R&D-specific intelligence, materially better than fragmented stacks where data preparation and AI agents come from separate vendors

Limitations

• ⚠Enterprise-only pricing inaccessible to academic and SMB users — Iris.ai deployments at $200K+/year exclude individual researchers, academic teams, and smaller organizations that the original Iris.ai academic research engine served
• ⚠Pivot from academic research to enterprise creates customer continuity considerations — researchers who used Iris.ai as an academic search tool may find current enterprise positioning less applicable, and academic-context resources are less prominent than in earlier years
• ⚠Implementation complexity from data foundation depth — building enterprise knowledge graphs and AI-ready data foundations requires sustained data engineering investment beyond just AI agent deployment